While the company has offered the technique for more than a decade it has recently begun exploring its suitability for larger-scale plasma proteomic studies.
Of the total, $1 billion will be used to expand viral genome sequencing while the remainder will fund genomic epidemiology centers and new bioinformatics infrastructure.
At ACMG, researchers presented results from an ongoing effort using a growing sample collection to find genetic contributors to severe viral infections in children.
